Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
996 DKK | -2.33% | -5.07% | -25.11% |
Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
5.12M | - | - | - | - | - | |
118B | ||||||
106B | ||||||
23.4B | - | |||||
21.78B | - | |||||
18.09B |
- Stock Market
- Equities
- ORPHA Stock
- Charts Orphazyme A/S
- Sector Chart